Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population‐based cohort study

Treatment with direct oral anticoagulants or warfarin and the risk for incident diabetes among patients with atrial fibrillation: a population‐based cohort study

Abstract Background Diabetes mellitus is a common comorbidity of atrial fibrillation (AF), which can complicate the management of AF. The pharmacology of oral anticoagulants (OACs) have been implicated in pathogenesis of diabetes, but the relationship between different OACs and risk of diabetes rema...

Full description

Bibliographic Details
Main Authors: Ching-Lung Cheung, Chor-Wing Sing, Wallis C. Y. Lau, Gloria H. Y. Li, Gregory Y. H. Lip, Kathryn C. B. Tan, Bernard M. Y. Cheung, Esther W. Y. Chan, Ian C. K. Wong
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Cardiovascular Diabetology
Subjects:
Diabetes
Atrial fibrillation
Anti-coagulant
Pharmacoepidemiology
DOAC
Warfarin
Online Access:https://doi.org/10.1186/s12933-021-01263-0

Internet

https://doi.org/10.1186/s12933-021-01263-0

Similar Items